Actuate Therapeutics, Inc. SEC filings ACTU
Actuate Therapeutics, Inc. has 192 filings in SEC EDGAR's recent list, going back to Oct 8, 2015. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice
|
Oct 30, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 28, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 17, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2026 | May 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 11, 2026 | May 11, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
May 6, 2026 | May 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Material agreement
|
Nov 28, 2025 | Nov 28, 2025 |
| 8-K |
Current report
Other events
|
Nov 21, 2025 | Nov 21, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 10, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 26, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 5, 2025 | May 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 2, 2025 | May 31, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2025 | May 22, 2025 |
| 8-K |
Current report
Other events
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 28, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Other events
|
Feb 7, 2025 | Feb 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 17, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Auditor change
|
Aug 19, 2024 | Aug 19, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Other events
|
Aug 14, 2024 | Aug 14, 2024 |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACTU (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Fort Worth, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1652935
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.